PYRAMID Registry: Observational Study of Adalimumab in Crohn's Disease at Year 2

被引：0
|
作者：
D'Haens, Geert [1 ]
Reinisch, Walter [2 ]
Satsangi, Jack [3 ]
Loftus, Edward [4 ]
Panaccione, Remo [5 ]
Tokimoto, Debbie [6 ]
McNamee, Lawrence [6 ]
Lomax, Kathleen [6 ]
机构：
[1] Imelda GI Clin Res Ctr, Bonheiden, Belgium
[2] Med Univ Vienna, Vienna, Austria
[3] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Mayo Clin, Rochester, MN USA
[5] Univ Calgary, Calgary, AB, Canada
[6] Abbott, Abbott Pk, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷
关键词：
D O I：
10.14309/00000434-201010001-01183
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1183
引用
收藏
页码：S431 / S431
页数：1
相关论文
共 50 条
  • [21] PYRAMID Registry: Long-term Safety and Effectiveness of Adalimumab by Baseline Immunomodulator Use in Patients With Crohn's Disease
    Reinisch, Walter
    Panaccione, Remo
    D'Haens, Geert
    Loftus, Edward V., Jr.
    Satsangi, Jack
    Colombel, Jean-Frederic
    Alperovich, Gabriela
    Berg, Sofie
    Kalabic, Jasmina
    Bereswill, Mareike
    Petersson, Joel
    Robinson, Anne M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S384 - S384
  • [22] Long-term effectiveness and safety of adalimumab based on Crohn's disease duration: Results from the PYRAMID registry
    Loftus, E. V., Jr.
    Reinisch, W.
    Panaccione, R.
    Berg, S.
    Bereswill, M.
    Kalabic, J.
    Skup, M.
    Petersson, J.
    Robinson, A. M.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S493 - S494
  • [23] IMPACT OF TREATMENT RESPONSE WITH ADALIMUMAB ON RISK OF SERIOUS INFECTIONS IN PATIENTS WITH CROHN'S DISEASE: SECONDARY ANALYSIS OF THE PYRAMID REGISTRY
    Ahuja, Dhruv
    Luo, Jiyu
    Qi, Yuchen
    Syal, Gaurav
    Boland, Brigid
    Chang, John
    Ma, Christopher
    Jairath, Vipul
    Xu, Ronghui
    Singh, Siddharth
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S1 - S1
  • [24] LONG-TERM EFFECTIVENESS AND SAFETY OF ADALIMUMAB BASED ON CROHN'S DISEASE DURATION: RESULTS FROM THE PYRAMID REGISTRY
    Loftus, Edward V.
    Reinisch, Walter
    Panaccione, Remo
    Berg, Sofie
    Bereswill, Mareike
    Kalabic, Jasmina
    Skup, Martha
    Petersson, Joel H.
    Robinson, Anne M.
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2018, 154 (06) : S403 - S403
  • [25] IMPACT OF TREATMENT RESPONSE WITH ADALIMUMAB ON RISK OF SERIOUS INFECTIONS IN PATIENTS WITH CROHN'S DISEASE: SECONDARY ANALYSIS OF THE PYRAMID REGISTRY
    Ahuja, Dhruv
    Luo, Jiyu
    Qi, Yuchen
    Syal, Gaurav
    Boland, Brigid
    Chang, John
    Ma, Christopher
    Jairath, Vipul
    Xu, Ronghui
    Singh, Siddharth
    GASTROENTEROLOGY, 2024, 166 (03) : S1 - S1
  • [26] Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan
    Fuminao Takeshima
    Daisuke Yoshikawa
    Syuntaro Higashi
    Tomohito Morisaki
    Hidetoshi Oda
    Maho Ikeda
    Haruhisa Machida
    Kayoko Matsushima
    Hitomi Minami
    Yuko Akazawa
    Naoyuki Yamaguchi
    Ken Ohnita
    Hajime Isomoto
    Masato Ueno
    Kazuhiko Nakao
    BMC Gastroenterology, 16
  • [27] Adalimumab and Infliximab As Induction Therapy for Crohn's Disease - A Prospective Observational Study in Germany
    Bokemeyer, Bernd
    Helwig, Ulf
    Teich, Niels
    Schmidt, Carsten
    Krummenerl, Thomas
    Rupf, Ann-Katrin
    Hartmann, Heinz
    Blaker, Michael
    Krummenerl, Annette
    Duffelmeyer, Marc
    Hinrichs, Regina
    Hartmann, Petra
    Nikolaus, Susanna
    Huppe, Dietrich
    Schreiber, Stefan
    GASTROENTEROLOGY, 2014, 146 (05) : S453 - S453
  • [28] Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study
    Ribaldone, Davide Giuseppe
    Caviglia, Gian Paolo
    Pellicano, Rinaldo
    Vernero, Marta
    Saracco, Giorgio Maria
    Morino, Mario
    Astegiano, Marco
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (03) : 195 - 200
  • [29] Clinical efficacy of adalimumab in Crohn's disease: a real practice observational study in Japan
    Takeshima, Fuminao
    Yoshikawa, Daisuke
    Higashi, Syuntaro
    Morisaki, Tomohito
    Oda, Hidetoshi
    Ikeda, Maho
    Machida, Haruhisa
    Matsushima, Kayoko
    Minami, Hitomi
    Akazawa, Yuko
    Yamaguchi, Naoyuki
    Ohnita, Ken
    Isomoto, Hajime
    Ueno, Masato
    Nakao, Kazuhiko
    BMC GASTROENTEROLOGY, 2016, 16
  • [30] Adalimumab in Crohn's disease
    Van Assche, Gert
    Vermeire, Severine
    Rutgeerts, Paul
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 355 - 365
12345